InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2026-04-16 19:58:04 ET · period of report 2026-04-15 · accession 0001737840-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-04-16 19:58 2026-04-15 GH Saia John G. CLO M - OptEx $0.00 +7,569 69.9K +12% $0
D 2026-04-16 19:58 2026-04-15 GH Saia John G. CLO F - Tax $84.86 -3,970 66.0K -6% -$336.9K
D 2026-04-16 19:58 2026-04-15 GH Saia John G. CLO M - OptEx $0.00 -7,569 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-04-15 M A 7,569 $0.00 69,920 D — —
2 Common Common Stock 2026-04-15 F D 3,970 $84.86 65,950 D — — (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
3 Derivative Restricted Stock Units 2026-04-15 M D 7,569 $0.00 0 D $0.00 · — to — 7,569 Common Stock (F2) The restricted stock unit award granted on August 8, 2022 vests over a four-year period. 25% of the shares subject to such award vested on April 15, 2023 and the remaining 75% vests annually during the three-year period thereafter. (F3) Not applicable for Restricted Stock Units.